Logo image of ELSE

ELECTRO-SENSORS INC (ELSE) Stock Fundamental Analysis

NASDAQ:ELSE - US2852331022 - Common Stock

4.57 USD
-0.07 (-1.55%)
Last: 9/3/2025, 11:20:51 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ELSE. ELSE was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. While ELSE has a great health rating, its profitability is only average at the moment. ELSE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year ELSE was profitable.
ELSE had a positive operating cash flow in the past year.
Of the past 5 years ELSE 4 years were profitable.
Of the past 5 years ELSE 4 years had a positive operating cash flow.
ELSE Yearly Net Income VS EBIT VS OCF VS FCFELSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K 1M

1.2 Ratios

ELSE's Return On Assets of 2.86% is fine compared to the rest of the industry. ELSE outperforms 63.20% of its industry peers.
ELSE has a Return On Equity of 3.02%. This is comparable to the rest of the industry: ELSE outperforms 56.00% of its industry peers.
ELSE has a Return On Invested Capital of 0.16%. This is comparable to the rest of the industry: ELSE outperforms 48.00% of its industry peers.
Industry RankSector Rank
ROA 2.86%
ROE 3.02%
ROIC 0.16%
ROA(3y)1.87%
ROA(5y)1.53%
ROE(3y)1.95%
ROE(5y)1.61%
ROIC(3y)N/A
ROIC(5y)N/A
ELSE Yearly ROA, ROE, ROICELSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

ELSE has a better Profit Margin (4.54%) than 67.20% of its industry peers.
In the last couple of years the Profit Margin of ELSE has grown nicely.
ELSE has a Operating Margin (0.34%) which is in line with its industry peers.
ELSE's Gross Margin of 49.91% is amongst the best of the industry. ELSE outperforms 85.60% of its industry peers.
ELSE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.34%
PM (TTM) 4.54%
GM 49.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-0.02%
PM growth 5Y15.65%
GM growth 3Y-3.47%
GM growth 5Y-1.57%
ELSE Yearly Profit, Operating, Gross MarginsELSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELSE is destroying value.
The number of shares outstanding for ELSE has been increased compared to 1 year ago.
The number of shares outstanding for ELSE has been increased compared to 5 years ago.
There is no outstanding debt for ELSE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ELSE Yearly Shares OutstandingELSE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ELSE Yearly Total Debt VS Total AssetsELSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

An Altman-Z score of 15.24 indicates that ELSE is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 15.24, ELSE belongs to the best of the industry, outperforming 93.60% of the companies in the same industry.
There is no outstanding debt for ELSE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.24
ROIC/WACC0.02
WACC9.38%
ELSE Yearly LT Debt VS Equity VS FCFELSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 17.92 indicates that ELSE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 17.92, ELSE belongs to the top of the industry, outperforming 96.80% of the companies in the same industry.
ELSE has a Quick Ratio of 15.31. This indicates that ELSE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 15.31, ELSE belongs to the top of the industry, outperforming 96.80% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 17.92
Quick Ratio 15.31
ELSE Yearly Current Assets VS Current LiabilitesELSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

ELSE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 113.07%, which is quite impressive.
The Earnings Per Share has been growing by 16.69% on average over the past years. This is quite good.
Looking at the last year, ELSE shows a quite strong growth in Revenue. The Revenue has grown by 8.08% in the last year.
Measured over the past years, ELSE shows a small growth in Revenue. The Revenue has been growing by 2.56% on average per year.
EPS 1Y (TTM)113.07%
EPS 3Y2.65%
EPS 5Y16.69%
EPS Q2Q%1483.33%
Revenue 1Y (TTM)8.08%
Revenue growth 3Y2.87%
Revenue growth 5Y2.56%
Sales Q2Q%8.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ELSE Yearly Revenue VS EstimatesELSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 35.15, ELSE can be considered very expensive at the moment.
ELSE's Price/Earnings is on the same level as the industry average.
ELSE's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.90.
Industry RankSector Rank
PE 35.15
Fwd PE N/A
ELSE Price Earnings VS Forward Price EarningsELSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ELSE is on the same level as its industry peers.
ELSE's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 53.63
EV/EBITDA 46.89
ELSE Per share dataELSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.11
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ELSE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ELECTRO-SENSORS INC

NASDAQ:ELSE (9/3/2025, 11:20:51 AM)

4.57

-0.07 (-1.55%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-08 2025-08-08
Earnings (Next)11-11 2025-11-11
Inst Owners14.64%
Inst Owner Change11.03%
Ins Owners52.37%
Ins Owner Change0%
Market Cap15.77M
Analysts0
Price TargetN/A
Short Float %1.13%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 35.15
Fwd PE N/A
P/S 1.65
P/FCF 53.63
P/OCF 47.49
P/B 1.1
P/tB 1.1
EV/EBITDA 46.89
EPS(TTM)0.13
EY2.84%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.09
FCFY1.86%
OCF(TTM)0.1
OCFY2.11%
SpS2.77
BVpS4.17
TBVpS4.17
PEG (NY)N/A
PEG (5Y)2.11
Profitability
Industry RankSector Rank
ROA 2.86%
ROE 3.02%
ROCE 0.22%
ROIC 0.16%
ROICexc 0.56%
ROICexgc 0.56%
OM 0.34%
PM (TTM) 4.54%
GM 49.91%
FCFM 3.08%
ROA(3y)1.87%
ROA(5y)1.53%
ROE(3y)1.95%
ROE(5y)1.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-0.02%
PM growth 5Y15.65%
GM growth 3Y-3.47%
GM growth 5Y-1.57%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 42.22%
Cap/Sales 0.4%
Interest Coverage 5.33
Cash Conversion 272.13%
Profit Quality 67.74%
Current Ratio 17.92
Quick Ratio 15.31
Altman-Z 15.24
F-Score6
WACC9.38%
ROIC/WACC0.02
Cap/Depr(3y)58.86%
Cap/Depr(5y)46.31%
Cap/Sales(3y)0.71%
Cap/Sales(5y)0.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)113.07%
EPS 3Y2.65%
EPS 5Y16.69%
EPS Q2Q%1483.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.08%
Revenue growth 3Y2.87%
Revenue growth 5Y2.56%
Sales Q2Q%8.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y122.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y520%
FCF growth 3Y-50.16%
FCF growth 5YN/A
OCF growth 1Y1760%
OCF growth 3Y-44.87%
OCF growth 5Y-2.97%